Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients

被引:46
作者
Bucaneve, Giampaolo [1 ]
Castagnola, Elio
Viscoli, Claudio
Leibovici, Leonard
Menichetti, Francesco
机构
[1] Azienda Osped Perugia, Ist Med Interna & Sci Oncol, Monteluce Policlin, I-06100 Perugia, Italy
[2] Osped G Gaslini, Dipartimento Ematol & Oncol, Unita Malattie Infett, Genoa, Italy
[3] Univ Genoa, Azienda Osped Univ San Martino, Clin Malattie Infett, Genoa, Italy
[4] E Rabin Med Ctr, Dept Med, Petah Tiqwa, Israel
[5] Osped Cisanello, Unita Malattie Infett, Pisa, Italy
来源
EJC SUPPLEMENTS | 2007年 / 5卷 / 02期
关键词
neutropenia; acute leukaemia; haematopoietic stem cell transplantation (HSCT); antibiotic prophylaxis; Quinolones Levofloxacin; ciprofloxacin; ofloxacin; norfloxacin;
D O I
10.1016/j.ejcsup.2007.06.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
These recommendations have been developed by an expert panel following an evidence-based search of the literature assessing the role of fluoroquinolones in the prevention of bacterial infection in patients with acute leukaemia or bone marrow transplantation and neutropenia. We present results from a questionnaire on the current practice among experts in Europe, show results of the literature search, review recommendations available from other international guidelines and provide the panel's recommendations. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5 / 12
页数:8
相关论文
共 39 条
[1]   The effect of ciprofloxacin on cyclophosphamide pharmacokinetics in patients with non-Hodgkin lymphoma [J].
Afsharian, P ;
Möllgård, L ;
Hassan, Z ;
Xie, HJ ;
Kimby, E ;
Hassan, M .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (03) :206-211
[2]   Prophylactic antimicrobial agents and the importance of fitness [J].
Baden, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :1052-1054
[3]  
BRODSKY AL, 1993, MEDICINA-BUENOS AIRE, V53, P401
[4]   Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia [J].
Bucaneve, G ;
Micozzi, A ;
Menichetti, F ;
Martino, P ;
Dionisi, MS ;
Martinelli, G ;
Allione, B ;
D'Antonio, D ;
Buelli, M ;
Nosari, AM ;
Cilloni, D ;
Zuffa, E ;
Cantaffa, R ;
Specchia, G ;
Amadori, S ;
Fabbiano, F ;
Deliliers, GL ;
Lauria, F ;
Foà, R ;
Del Favero, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :977-987
[5]  
Carlens S, 1998, CLIN TRANSPLANT, V12, P84
[6]   Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: A randomized trial [J].
Carlson, JW ;
Fowler, JM ;
Mitchell, SK ;
Carson, LF ;
Mayer, AR ;
Copeland, LJ .
GYNECOLOGIC ONCOLOGY, 1997, 65 (02) :325-329
[7]   EMERGENCE OF QUINOLONE-RESISTANT ESCHERICHIA-COLI BACTEREMIA IN NEUTROPENIC PATIENTS WITH CANCER WHO HAVE RECEIVED PROPHYLACTIC NORFLOXACIN [J].
CARRATALA, J ;
FERNANDEZSEVILLA, A ;
TUBAU, F ;
CALLIS, M ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :557-560
[8]  
CASALI A, 1988, CHEMIOTERAPIA, V7, P327
[9]   Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres [J].
Castagnola, E ;
Haupt, R ;
Micozzi, A ;
Caviglia, I ;
Testi, AM ;
Giona, F ;
Parodi, S ;
Girmenia, C .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (06) :505-507
[10]   Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis [J].
Cruciani, M ;
Rampazzo, R ;
Malena, M ;
Lazzarini, L ;
Todeschini, G ;
Messori, A ;
Concia, E .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :795-805